Back to Search
Start Over
COVID-19 and emerging viral infections: The case for interferon lambda
- Source :
- The Journal of Experimental Medicine; May 2020, Vol. 217 Issue: 5 pe20200653-e20200653, 1p
- Publication Year :
- 2020
-
Abstract
- With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and other emerging viral infections. In this Viewpoint, we present our opinion on the benefits and potential limitations of using IFN-λ to prevent, limit, and treat these dangerous viral infections.
Details
- Language :
- English
- ISSN :
- 00221007 and 15409538
- Volume :
- 217
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- The Journal of Experimental Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs55325627
- Full Text :
- https://doi.org/10.1084/jem.20200653